Physician profile
Khizer Sikander
NPI 1962744805
$6,383.49
in general payments reported to CMS, 2019-2025
24 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $36.58 · 2021: $901 · 2022: $629 · 2023: $3,148 · 2024: $971 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,416 · Travel and Lodging: $1,279 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,415.97 |
| Travel and Lodging | $1,279.15 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,860.62 | 2023-2025 | Impella |
| Medtronic, INC. | $1,466.32 | 2021-2025 | Micra, Mycarelink, Corevalve Evolut R |
| Shockwave Medical, INC | $632.01 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $364.24 | 2021-2024 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Rotapro |
| Abbott Laboratories | $362.02 | 2021-2023 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $233.86 | 2021-2024 | Lifevest |
| Cvrx, INC. | $219.71 | 2023-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $201.16 | 2022-2025 | Optimizer |
| Terumo Medical Corporation | $146.26 | 2023 | Metacross Otw, Glidewire, Glidesheath Slender |
| Novartis Pharmaceuticals Corporation | $144.29 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $126.48 | 2019-2020 | |
| Philips North America LLC | $125.41 | 2024 | (Az7) Lasers |
| Janssen Pharmaceuticals, INC | $124.50 | 2021 | |
| Pfizer INC. | $61.08 | 2023-2024 | |
| Edwards Lifesciences Corporation | $60.40 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $42.67 | 2024 | Verquvo |
| Amgen INC. | $38.46 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.73 | 2023-2024 | Jardiance |
| Cordis US Corp. | $32.60 | 2023 | Mynx Control, Radial 360 |
| Kestra Medical Technology Services, INC. | $29.66 | 2024 | Assure Wcd |
| Baxter Healthcare | $29.36 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Livanova USA, INC. | $16.85 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $16.40 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $13.40 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khizer Sikander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.